发明名称 CARBOXYAMIDO DERIVATIVES
摘要 A carboxyamido derivative represented by formula (I) useful as a medicament for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity: wherein R<1> represents 2-hydroxybenzimidazolyl group which may be substituted and the like; Y represents oxygen atom or sulfur atom; R<2> represents hydrogen atom or an alkyl group; n represents 0, 1 or 2; at least one of X<1>, X<2>, X<3, X?4> and X<5> represent (a) NR<3>R<4>, (b) N+R<5>R<6>R<7>, or (c) a nitrogen-containing heterocyclic group having one or more sp<2> nitrogen atoms which may be substituted, in which R<3> and R<4> independently represent hydrogen atom, an alkyl group and the like, or R<3>, N and R<4> may combine together to form a nitrogen-containing heterocyclic group which may be substituted; R<5>, R<6> and R<7> represent an alkyl group and the like, or R<5>, N and R<6> may combine together to form a nitrogen-containing heterocyclic group which may be substituted; or neighboring X<2> and X<3> or X<3> and X<4> and the like may combine together with the benzene ring to form an isoindoline ring and the like, and the rest of them represent hydrogen atom.
申请公布号 WO0142224(A1) 申请公布日期 2001.06.14
申请号 WO2000JP08690 申请日期 2000.12.08
申请人 MITSUBISHI-TOKYO PHARMACEUTICALS, INC.;ANDO, RYOICHI;ARITOMO, KEIICHI;SHODA, AYA;WATANABE, KAZUTOSHI;UEHARA, FUMIAKI;SAITO, KEN-ICHI 发明人 ANDO, RYOICHI;ARITOMO, KEIICHI;SHODA, AYA;WATANABE, KAZUTOSHI;UEHARA, FUMIAKI;SAITO, KEN-ICHI
分类号 A61P7/04;C07D235/02;C07D235/26;C07D401/12;(IPC1-7):C07D235/26;A61K31/418 主分类号 A61P7/04
代理机构 代理人
主权项
地址